Works by Takeuchi, Naoko


Results: 32
    1
    2
    3

    Decrease of cytokinin flux from roots enhances degradation of ribulose-1,5-bisphosphate carboxylase/oxygenase: a mechanism of the accelerated decrease of leaf photosynthesis with senescence under soil moisture stress in rice (Oryza sativa L.).

    Published in:
    Plant & Soil, 2024, v. 496, n. 1/2, p. 391, doi. 10.1007/s11104-023-06367-y
    By:
    • Nakanishi, Koji;
    • Fujiki, Hiroko;
    • Ozaki, Koichi;
    • Yanahara, Satoko;
    • Takeuchi, Naoko;
    • Suzuki, Yuji;
    • Sugiyama, Tamiji;
    • Makino, Amane;
    • Ookawa, Taiichiro;
    • Hirasawa, Tadashi
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.

    Published in:
    Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-014-0474-x
    By:
    • Tamiya, Akihiro;
    • Tamiya, Motohiro;
    • Shiroyama, Takayuki;
    • Saijo, Nobuhiko;
    • Nakatani, Takeshi;
    • Minomo, Shojiro;
    • Tsuji, Taisuke;
    • Takeuchi, Naoko;
    • Omachi, Naoki;
    • Kurata, Kanako;
    • Suzuki, Hidekazu.;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Atagi, Shinji
    Publication type:
    Article
    12
    13
    14
    15
    16

    Electrogastrography abnormality in eating disorders.

    Published in:
    Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 3, p. 300, doi. 10.1111/j.1440-1819.2004.01236.x
    By:
    • OGAWA, ASAO;
    • MIZUTA, ICHIRO;
    • FUKUNAGA, TOMOKO;
    • TAKEUCHI, NAOKO;
    • HONAGA, EIKO;
    • SUGITA, YOSHIRO;
    • MIKAMI, AKIRA;
    • INOUE, YOICHI;
    • TAKEDA, MASATOSHI
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 4, p. 1106, doi. 10.1007/s10637-021-01076-8
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Suzuki, Hidekazu;
    • Taniguchi, Yoshihiko;
    • Katayama, Kanako;
    • Minomo, Shojiro;
    • Nakao, Keiko;
    • Takeuchi, Naoko;
    • Matsuda, Yoshinobu;
    • Naito, Yujiro;
    • Shiroyama, Takayuki;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kumagai, Toru;
    • Atagi, Shinji;
    • Imamura, Fumio;
    • Hirashima, Tomonori
    Publication type:
    Article
    27
    28
    29
    30
    31
    32